The latest closing stock price for Sage Therapeutics as of November 08, 2024 is 6.31.
An investor who bought $1,000 worth of Sage Therapeutics stock at the IPO in 2014 would have $-790 today, roughly -1 times their original investment - a -14.46% compound annual growth rate over 10 years.
The all-time high Sage Therapeutics stock closing price was 192.33 on February 01, 2018.
The Sage Therapeutics 52-week high stock price is 28.26, which is 347.9% above the current share price.
The Sage Therapeutics 52-week low stock price is 5.64, which is 10.6% below the current share price.
The average Sage Therapeutics stock price for the last 52 weeks is 14.69.
An investor who bought $1,000 worth of Sage Therapeutics stock at the IPO in 2014 would have $-790 today, roughly -1 times their original investment - a -14.46% compound annual growth rate over 10 years.
The all-time high Sage Therapeutics stock closing price was 192.33 on February 01, 2018.
The Sage Therapeutics 52-week high stock price is 28.26, which is 347.9% above the current share price.
The Sage Therapeutics 52-week low stock price is 5.64, which is 10.6% below the current share price.
The average Sage Therapeutics stock price for the last 52 weeks is 14.69.